Literature DB >> 21728387

Feasibility of non-coplanar tomotherapy for lung cancer stereotactic body radiation therapy.

Wensha Yang1, Ryan Jones, Weiguo Lu, Constance Geesey, Stanley Benedict, Paul Read, James Larner, Ke Sheng.   

Abstract

To quantify the dosimetric gains from non-coplanar helical tomotherapy (HT) arcs for stereotactic body radiation therapy (SBRT) of lung cancer, we created oblique helical arcs by rotating patient's CT images. Ten, 20 and 30 degrees of yaws were introduced in the treatment planning for a patient with a hypothetical lung tumor at the upper, middle and lower portion of the right lung, and the upper and middle left lung. The planning target volume (PTV) was 43 cm(3). 60 Gy was prescribed to the PTV. Dose to organs at risk (OARs), which included the lungs, heart, spinal cord and chest wall, was optimized using a 2.5 cm jaw, 0.287 pitch and modulation factor of 2.5. Composite plans were generated by dose summation of the resultant plans. These plans were evaluated for its conformity index (R(x)) and percentile volume of lung receiving radiation dose of x Gy (V(x)). Conformity index was defined by the ratio of x percent isodose volume and PTV. The results show that combination of non-coplanar arcs reduced R(50) by 4.5%, R(20) by 26% and R(10) by 30% on average. Non-coplanar arcs did not affect V(20) but reduced V(10) and V(5) by 10% and 24% respectively. Composite of the non-coplanar arcs also reduced maximum dose to the spinal cord by 20-39%. Volume of chest wall receiving higher than 30 Gy was reduced by 48% on average. Heart dose reduction was dependent on the location of the PTV and the choice of non-coplanar orientations. Therefore we conclude that non-coplanar HT arcs significantly improve critical organ sparing in lung SBRT without changing the PTV dose coverage.

Entities:  

Mesh:

Year:  2011        PMID: 21728387     DOI: 10.7785/tcrt.2012.500207

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  5 in total

1.  Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.

Authors:  Robert D Timmerman; Rebecca Paulus; Harvey I Pass; Elizabeth M Gore; Martin J Edelman; James Galvin; William L Straube; Lucien A Nedzi; Ronald C McGarry; Cliff G Robinson; Peter B Schiff; Garrick Chang; Billy W Loo; Jeffrey D Bradley; Hak Choy
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

2.  Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.

Authors:  Robert D Timmerman; Chen Hu; Jeff M Michalski; Jeffrey C Bradley; James Galvin; David W Johnstone; Hak Choy
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

3.  Viability of Non-Coplanar VMAT for Liver SBRT as Compared to Coplanar VMAT and Beam Orientation Optimized 4π IMRT.

Authors:  Kaley Woods; Dan Nguyen; Angelia Tran; Victoria Y Yu; Minsong Cao; Tianye Niu; Percy Lee; Ke Sheng
Journal:  Adv Radiat Oncol       Date:  2016 Jan-Mar

4.  Dosimetric comparison of coplanar and noncoplanar beam arrangements for radiotherapy of patients with lung cancer: A meta-analysis.

Authors:  Min Ma; Wenting Ren; Minghui Li; Chuanmeng Niu; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2021-02-26       Impact factor: 2.102

5.  Noncoplanar Radiation using Tomotherapy: A Phantom Study.

Authors:  Masahiro Yuasa; Hiromasa Kurosaki
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.